A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.

K WangY LiJ WangR ChenJianxiang Li

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)

The 12-gene prognostic model may serve as a useful complementary clinical risk-stratification tool for stage I and especially stage IA lung squamous cell carcinoma patients to guide clinical decision making.

Keyphrases

squamous cell carcinoma
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
decision making
peritoneal dialysis
gene expression
dna methylation
lymph node metastasis
transcription factor
patient reported outcomes